Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: The EBMT experience

Ugo De Giorgi*, T. Demirer, H. Wandt, C. Taverna, W. Siegert, M. Bornhauser, T. Kozak, G. Papiani, M. Ballardini, G. Rosti, M. Marangolo, G. Ehninger, M. Suttorp, Carl Gustav Carus, D. Lutz, A. P. Schwarer, A. Thyss, H. Ludwig, G. Baumgartner, B. LioureA. Gratwohl, B. Hertenstein, K. Welte, R. Blasczyk, Y. Beguin, B. Metzner, K. Orchard, J. Garcia-Conde, C. Devalck, A. D. Moicean, R. Marcus, S. McCann, S. A. Schey, G. Juliusson, S. Lenhoff, K. Kolbe, E. Morra, J. F. Rossi, I. Yaniv, V. Koza, M. Freund, M. Bjorkholm, H. Greinix, W. Hinterberger

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: The EBMT experience'. Together they form a unique fingerprint.

Medicine & Life Sciences